PuSH - Publication Server of Helmholtz Zentrum München

Circulating and disseminated tumor cells: Diagnostic tools and therapeutic targets in motion.

Oncotarget 8, 1884-1912 (2017)
Publishers Version DOI PMC
Free by publisher
as soon as is submitted to ZB.
Enumeration of circulating tumor cells (CTCs) in peripheral blood with the gold standard CellSearchTM has proven prognostic value for tumor recurrence and progression of metastatic disease. Therefore, the further molecular characterization of isolated CTCs might have clinical relevance as liquid biopsy for therapeutic decision-making and to monitor disease progression. The direct analysis of systemic cancer appears particularly important in view of the known disparity in expression of therapeutic targets as well as epithelial-to-mesenchymal transition (EMT)-based heterogeneity between primary and systemic tumor cells, which all substantially complicate monitoring and therapeutic targeting at present. Since CTCs are the potential precursor cells of metastasis, their in-depth molecular profiling should also provide a useful resource for target discovery. The present review will discuss the use of systemically spread cancer cells as liquid biopsy and focus on potential target antigens.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Keywords CTCs; DTCs; EpCAM; MICs; metastases
Reviewing status
Institute(s) CCG Personalized Radiotherapy in Head and Neck Cancer (KKG-KRT)